deltatrials
Active Not Recruiting PHASE2 INTERVENTIONAL 1-arm NCT03972930

Hypofractionated Radiotherapy for Soft Tissue Sarcomas

Phase 2 Trial of Hypofractionated Radiotherapy for Soft Tissue Sarcomas

Sponsor: University of Wisconsin, Madison

Conditions Soft Tissue Sarcoma
Interventions Hypofractionated Radiotherapy
Updated 18 times since 2019 Last updated: Jan 15, 2025 Started: Jun 11, 2019 Primary completion: Nov 28, 2024 Completion: Dec 31, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Soft Tissue Sarcoma and is currently ongoing. University of Wisconsin, Madison leads this study, which shows 18 recorded versions since 2019 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Jul 2019 – ~Aug 2019 · 31 days · monthly snapshot~Aug 2019 – ~Dec 2019 · 4 months · monthly snapshot~Dec 2019 – ~Feb 2020 · 2 months · monthly snapshot~Feb 2020 – ~Mar 2020 · 29 days · monthly snapshot~Mar 2020 – ~May 2020 · 2 months · monthly snapshot~May 2020 – ~Jul 2020 · 2 months · monthly snapshot~Jul 2020 – ~Jan 2021 · 6 months · monthly snapshot~Jan 2021 – ~Apr 2021 · 3 months · monthly snapshot~Apr 2021 – ~Apr 2022 · 12 months · monthly snapshot~Apr 2022 – ~Sep 2022 · 5 months · monthly snapshot~Sep 2022 – ~Jan 2023 · 4 months · monthly snapshot~Jan 2023 – ~Jul 2023 · 6 months · monthly snapshot~Jul 2023 – ~Feb 2024 · 7 months · monthly snapshot~Feb 2024 – ~Jul 2024 · 5 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Oct 2024 · 30 days · monthly snapshot~Oct 2024 – ~Feb 2025 · 4 months · monthly snapshot~Feb 2025 – present · 17 months · monthly snapshot

Change History

18 versions recorded

  1. Feb 2025 — Present [monthly]

    Active Not Recruiting PHASE2

  2. Oct 2024 — Feb 2025 [monthly]

    Active Not Recruiting PHASE2

  3. Sep 2024 — Oct 2024 [monthly]

    Active Not Recruiting PHASE2

  4. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting PHASE2

  5. Feb 2024 — Jul 2024 [monthly]

    Active Not Recruiting PHASE2

▶ Show 13 earlier versions

  1. Jul 2023 — Feb 2024 [monthly]

    Active Not Recruiting PHASE2

  2. Jan 2023 — Jul 2023 [monthly]

    Active Not Recruiting PHASE2

    Status: Recruiting → Active Not Recruiting

  3. Sep 2022 — Jan 2023 [monthly]

    Recruiting PHASE2

  4. Apr 2022 — Sep 2022 [monthly]

    Recruiting PHASE2

  5. Apr 2021 — Apr 2022 [monthly]

    Recruiting PHASE2

  6. Jan 2021 — Apr 2021 [monthly]

    Recruiting PHASE2

  7. Jul 2020 — Jan 2021 [monthly]

    Recruiting PHASE2

  8. May 2020 — Jul 2020 [monthly]

    Recruiting PHASE2

    Status: Suspended → Recruiting

  9. Mar 2020 — May 2020 [monthly]

    Suspended PHASE2

    Status: Recruiting → Suspended

  10. Feb 2020 — Mar 2020 [monthly]

    Recruiting PHASE2

  11. Dec 2019 — Feb 2020 [monthly]

    Recruiting PHASE2

  12. Aug 2019 — Dec 2019 [monthly]

    Recruiting PHASE2

  13. Jul 2019 — Aug 2019 [monthly]

    Recruiting PHASE2

    First recorded

Jun 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • University of Wisconsin, Madison
Data source: University of Wisconsin, Madison

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations